| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,640 |
18,308 |
$1.73M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,867 |
12,275 |
$845K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
17,651 |
8,366 |
$495K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
10,474 |
4,014 |
$192K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
7,940 |
1,867 |
$128K |
| 20610 |
|
3,755 |
2,648 |
$128K |
| 99441 |
|
3,238 |
2,899 |
$121K |
| 99442 |
|
1,970 |
1,816 |
$117K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,078 |
1,042 |
$107K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
832 |
791 |
$91K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
784 |
761 |
$76K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,309 |
1,650 |
$60K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,449 |
4,545 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,256 |
1,135 |
$47K |
| 99215 |
Prolong outpt/office vis |
418 |
391 |
$44K |
| 20611 |
|
1,030 |
714 |
$27K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,593 |
3,946 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
9,028 |
8,527 |
$24K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
2,002 |
1,931 |
$22K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
136 |
133 |
$21K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,702 |
1,638 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,711 |
1,557 |
$18K |
| 93922 |
|
344 |
328 |
$17K |
| 99222 |
Initial hospital care, per day, moderate complexity |
366 |
341 |
$12K |
| 90674 |
|
538 |
532 |
$11K |
| 90756 |
|
595 |
543 |
$11K |
| 93000 |
|
914 |
853 |
$10K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
442 |
407 |
$9K |
| 90750 |
|
55 |
55 |
$8K |
| 99306 |
Prolong nursin fac eval 15m |
83 |
79 |
$6K |
| 90715 |
|
147 |
145 |
$5K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,848 |
1,482 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
521 |
473 |
$4K |
| 99315 |
|
98 |
92 |
$4K |
| 77080 |
|
143 |
140 |
$3K |
| 99385 |
|
28 |
26 |
$3K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
127 |
127 |
$3K |
| 20605 |
|
82 |
67 |
$2K |
| 94060 |
|
52 |
49 |
$2K |
| 99397 |
|
13 |
13 |
$1K |
| 99454 |
|
180 |
165 |
$1K |
| 99401 |
|
45 |
44 |
$1K |
| 94729 |
|
28 |
25 |
$1K |
| 90653 |
|
71 |
70 |
$892.02 |
| 94727 |
|
28 |
25 |
$822.65 |
| 90658 |
|
44 |
44 |
$669.48 |
| 99402 |
|
21 |
19 |
$660.81 |
| 99422 |
|
53 |
46 |
$512.80 |
| G0008 |
Administration of influenza virus vaccine |
220 |
207 |
$424.96 |
| 94200 |
|
28 |
25 |
$414.89 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
31 |
29 |
$379.97 |
| 99490 |
Ccm add 20min |
185 |
185 |
$372.15 |
| 69210 |
|
13 |
12 |
$278.58 |
| 92653 |
|
46 |
27 |
$261.16 |
| 95816 |
|
37 |
27 |
$176.66 |
| 95923 |
|
12 |
12 |
$172.45 |
| 95921 |
|
12 |
12 |
$170.03 |
| 3008F |
|
29,933 |
20,706 |
$170.00 |
| 81002 |
|
406 |
361 |
$155.45 |
| 99421 |
|
19 |
19 |
$126.12 |
| 99457 |
|
44 |
40 |
$111.56 |
| 94760 |
|
173 |
145 |
$111.04 |
| 99072 |
|
1,576 |
1,199 |
$100.00 |
| 96132 |
|
38 |
26 |
$87.84 |
| 93040 |
|
50 |
40 |
$60.39 |
| 82962 |
|
145 |
115 |
$58.35 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
16 |
13 |
$21.41 |
| 3061F |
|
508 |
496 |
$0.00 |
| 3074F |
|
7,949 |
5,996 |
$0.00 |
| 1000F |
|
1,241 |
1,112 |
$0.00 |
| G9231 |
Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period |
702 |
423 |
$0.00 |
| 3079F |
|
4,191 |
3,392 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
6,534 |
4,213 |
$0.00 |
| 3048F |
|
286 |
277 |
$0.00 |
| 1036F |
|
5,352 |
4,646 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
702 |
591 |
$0.00 |
| 3080F |
|
1,396 |
1,192 |
$0.00 |
| 3014F |
|
452 |
382 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
406 |
365 |
$0.00 |
| 3044F |
|
1,560 |
1,452 |
$0.00 |
| 3011F |
|
1,025 |
983 |
$0.00 |
| 1170F |
|
8,892 |
6,013 |
$0.00 |
| 1034F |
|
15 |
14 |
$0.00 |
| 1126F |
|
5,354 |
4,094 |
$0.00 |
| 1125F |
|
3,321 |
2,706 |
$0.00 |
| 3075F |
|
2,806 |
2,309 |
$0.00 |
| 3049F |
|
182 |
177 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
326 |
312 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
23,669 |
17,303 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
190 |
171 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
6,371 |
4,117 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
732 |
615 |
$0.00 |
| 3078F |
|
6,884 |
5,277 |
$0.00 |
| 3077F |
|
1,737 |
1,461 |
$0.00 |
| 1160F |
|
10,149 |
6,688 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,074 |
1,233 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
31 |
26 |
$0.00 |
| 4004F |
|
274 |
245 |
$0.00 |
| 3050F |
|
155 |
152 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
70 |
69 |
$0.00 |
| 4040F |
|
51 |
46 |
$0.00 |
| 3051F |
|
13 |
12 |
$0.00 |